AC Immune SA cofounder and CEO Andrea Pfeifer offers lessons in strategy and resilience for building and maintaining a drug ...

To unlock value and avoid costly mistakes, life sciences BD teams must work with commercial teams to help evaluate potential ...

Brian Lortie, president and CEO at Uniquity Bio, offered up key insights on building teams, securing capital, and operating with efficiency during a recent Business of Biotech podcast recording.

On this episode of the Business of Biotech, host Ben Comer speaks with Brian Lortie, President and CEO of Uniquity Bio, about his "no jerk" policy and how his experience building teams at GSK, Endo ...

Life sciences companies face an impending “tax policy trifecta” including potential TCJA expiration, U.S. trade and ...